What has been slower to emerge is a framework that recognizes these not as independent problems but as coordinated consequences of a single underlying disruption: the withdrawal of hormonal signals that had, for decades, been quietly governing cellular energy regulation, inflammatory tone, and tissue maintenance throughout the body
Hiramatsu M et al
GLP-1 receptor agonists have gained attention primarily for weight loss, yet mounting clinical evidence indicates they may also address systemic inflammationa silent driver of cardiovascular disease, type 2 diabetes, and metabolic dysfunction
The FDA granted the application a Priority Review designation, and the drug also received a Commissioner National Priority Voucher, which could further accelerate the review process
Smart storage habits at home The best storage spot in your fridge is not the door
Both options are effective for weight loss, using the GLP-1 pathway